Table 3 of Tiercy, Mol Vis 2010; 16:353-358.
Allele |
VKH patient alleles (2n=188) |
SO patient alleles (2n=78) |
Control subject alleles (2n=224) |
VKH versus controls |
SO versus controls |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
number | % | number | % | number | % | OR | 95% CI | p-value† | OR | 95% CI | p-value† | |
HLA-DRB1*0101 | 4 | 2.1 | 1 | 1.3 | 4 | 1.8 | 1.20 | 0.30–4.85 | 1 | 0.71 | 0.08–6.49 | 1 |
HLA-DRB1*0403 | 18 | 9.6 | 7 | 9.0 | 16 | 7.1 | 1.38 | 0.68–2.78 | 0.38 | 1.28 | 0.51–3.24 | 0.62 |
HLA-DRB1*0405 | 10 | 5.3 | 1 | 1.3 | 1 | 0.4 | 12.5 | 1.59–98.8 | 0.003# | 2.90 | 0.18–46.9 | 0.45 |
HLA-DRB1*0407 | 1 | 0.5 | 0 | 0.0 | 0 | 0.0 | 3.59 | 0.15–88.7 | 0.46 | n.a. | n.a. | n.a. |
HLA-DRB1*0410 | 6 | 3.2 | 2 | 2.6 | 1 | 0.4 | 7.35 | 0.88–61.6 | 0.051 | 5.87 | 0.53–65.6 | 0.17 |
HLA-DRB1*0405 or *0410 | 16 | 8.5 | 3 | 3.8 | 2 | 0.9 | 10.3 | 2.34–45.5 | <0.001 | 4.44 | 0.73–27.1 | 0.11 |